CISD2 and metabolic dysfunction-associated steatohepatitis: Hepatocyte-specific Cisd2-haploinsufficiency (Cisd2hKO+/−) aggravates nonalcoholic steatohepatitis (NASH) development and upregulates expression of the mRNAs responsible for cholesterol synthesis, fibrosis and lipid metabolism [4].